Ignite Creation Date:
2025-12-24 @ 2:34 PM
Ignite Modification Date:
2026-03-29 @ 11:50 PM
Study NCT ID:
NCT00265759
Status:
COMPLETED
Last Update Posted:
2025-04-23
First Post:
2005-12-14
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Exemestane, Letrozole, or Anastrozole in Treating Postmenopausal Women Who Are Undergoing Surgery for Stage II or Stage III Breast Cancer
Sponsor:
Alliance for Clinical Trials in Oncology
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
ACOSOG-Z1031
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None